Pharmalot… Pharmalittle… The Weekend Nears

Ready, get set, start daydreaming about the weekend. Another working week is about to draw to a close and already we are making our list of things to enjoy. These include spending time with the short people, catching up on some reading and taking a trip down the proverbial memory lane. But what about you? There are myriad ways to keep warm during this cold snap, such as gathering ’round the fireplace, taking in a movie at a theater that actually turns up the thermostat or downing a shot of scotch. The rest we will leave to your imagination. Whatever you do, have a grand time, but be safe. See you soon… Novartis CEO Dampens Talk Of Selling Roche Stake (Reuters) New England Compounding Creditors Seek $21M Clawback (Boston Business Journal) Novartis Receives Subpoena For Tekturna Marketing (Bloomberg News) Why Drug Names Begin With X And Z (Reuters) Watson Changes Its Name To Actavis (Drug Store News) Novartis Pulls EU Application For Gleevec For PAH (Pharma Times) Feds Indict Trio For Selling Unregulated Medicines (Nashville Tennesean) Global Vaccines Action Plan Slammed Over Pricing (Pharma Times) EDITOR’S NOTE: Please check this post for additional items during the day couch pic thx to ejegustafsson on flickr
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized Actavis New England Compounding Center Novartis Roche Tekturna Vaccines Watson Pharmaceuticals Source Type: blogs